Not provided
Not provided
Not provided
Not provided
Not provided
lack of funding
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to assess the impact of the innovative walking aid HIBBOT on the functions, activity and participation of young children with Cerebral Palsy, in comparison with conventional walking aids.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hibbot | Experimental |
| |
| Standard Care | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HIBBOT | Device | Hibbot is an assistive mechanical device, lightweight and portable. The mechanism of the Hibbot manages to control all degrees of freedom (3x rotation and 3x translation) at the level of the pelvis and lower trunk. The goal is to maximize a child's own muscle activity and postural control while giving as minimal support as needed. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Lower limb kinematics during walking in degrees | The gait pattern is assessed by instrumented 3D gait analysis. Joint rotation angles of the major joints of the lower limbs will be described during walking. | baseline (at intake, T0) and after the intervention period (3 months, T1) |
| Change in Muscle activation patterns during gait in microvolts | Surface electromyography signals will be recorded during gait | baseline (at intake, T0) and after the intervention period (3 months, T1) |
| Measure | Description | Time Frame |
|---|---|---|
| Lower limb kinematics during walking in degrees | The gait pattern is assessed by instrumented 3D gait analysis. Joint rotation angles of the major joints of the lower limbs will be described during walking. | at follow up (12 months after intake, T2) |
| Muscle activation patterns during gait in microvolts |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Antwerp | Antwerp | 2160 | Belgium |
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
At finalisation of the study and for a period of 5 years
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Not provided
Not provided
| ID | Term |
|---|---|
| D002547 | Cerebral Palsy |
| ID | Term |
|---|---|
| D001925 | Brain Damage, Chronic |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D059039 | Standard of Care |
| ID | Term |
|---|---|
| D019984 | Quality Indicators, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Standard Care | Other | Standard care involves the standard physiotherapy the child would get during clinical care. |
|
Surface electromyography signals will be recorded during gait |
| at follow up (12 months after intake, T2) |